Eculizumab monoclonal antibody drug. Targets complement component 5 and indications for use include paroxysmal nocturnal hemoglobinuria (PNH) and Atyp

---

Eculizumab monoclonal antibody drug. Targets complement component 5 and indications for use include paroxysmal nocturnal hemoglobinuria (PNH) and Atypical hemolytic uremic syndrome (aHUS). Generic name and stylized antibody.

---

Size: 9000px × 4944px
Photo credit: © molekuul.be / Alamy / Afripics
License: Royalty Free
Model Released: No

Keywords: ahus, antibody, atypical, biological, biosimilar, biotech, biotechnology, c5, cascade, complement, component, disease, drug, eculizumab, excessive, expensive, hemoglobinuria, hemolytic, immunoglobulin, immunology, infusion, inhibitor, injection, inn, mab, monoclonal, nocturnal, nomenclature, orphan, paroxysmal, peptide, pnh, price, protein, syndrome, terminal, uremic